Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | CLK1 | P49759 | 1/20 | 0.33 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.33 |
| ▸ | CCR1 | P32246 | 1/20 | 0.33 |
| ▸ | CCR8 | P51685 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25823206 | 0.83 | LIMK1 (0.36) | LMNACLK1LIMK1CCR1CCR8 | |
| SCHEMBL25519087 | 0.82 | ALDH1A1 (0.36) | ALDH1A1LMNASMN1; SMN2MAPTNPC1 | |
| SCHEMBL25823205 | 0.78 | — | — | |
| SCHEMBL25823204 | 0.78 | — | — | |
| SCHEMBL25823193 | 0.77 | MAPT (0.45) | ALDH1A1LMNASMN1; SMN2MAPTHPGD | |
| SCHEMBL25519091 | 0.74 | HRH4 (0.39) | ALDH1A1LMNAMAPTLIMK1L3MBTL1 | |
| SCHEMBL16283921 | 0.70 | L3MBTL1 (0.46) | ALDH1A1LMNASMN1; SMN2MAPTMAPK1 | |
| SCHEMBL25519006 | 0.69 | — | — | |
| SCHEMBL21032313 | 0.68 | ALOX5 (0.39) | CLK1LIMK1CCR1CCR8NPC1 | |
| SCHEMBL25494705 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230320210-A1 | HOST MATERIALS FOR ELECTROLUMINESCENT DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-10-05 | — | — | US | disclosed |
| US-11700766-B2 | Host materials for electroluminescent devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11700766-B2 | Host materials for electroluminescent devices | OR10J3, OCIAD2, MCM4 | ALDH1A1 2017/4885LMNA 1101/4885SMN1; SMN2 4552/4885 |
| US-20230320210-A1 | HOST MATERIALS FOR ELECTROLUMINESCENT DEVICES | OR10J3, OCIAD2, MCM4 | ALDH1A1 2017/4885LMNA 1101/4885SMN1; SMN2 4552/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.